NEONC TECHNOLOGIES HOLDINGS, INC. cotiza a 2.60 USD y tiene una capitalización bursátil de $75M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies. Its lead product candidates include NEO100, a purified form of preillyl acid that is in Phase IIa clinical trial; and NEO212, a covalently conjugated molecule combining chemothe…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | $-0.58 | $-0.38 | $-0.35 |
| Estimado | $-0.27 | $-0.17 | $-0.37 | $-0.37 |
| Sorpresa | — | -241.2% | -2.7% | +5.4% |
| Métrica | NTHI | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -145637.5% | -38.6% | -145598.9% |
| Net Margin | -155404.4% | -33.6% | -155370.8% |
| FCF Margin | -52172.9% | -13.9% | -52159.1% |
| ROE | — | -40.4% | — |
| ROA | -2200.9% | -32.0% | -2168.9% |
| Current Ratio | 0.07 | 2.84 | -2.77 |
| Debt / Equity | — | 0.28 | — |